{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:33:29Z","timestamp":1740126809633,"version":"3.37.3"},"reference-count":28,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aktuelle Urol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Bei der Low Compliance handelt es sich um keine eigene Krankheitsentit\u00e4t, sondern ein schweres Erscheinungsbild als Folge unterschiedlicher St\u00f6rungen der Speicher- und Ausscheidungsfunktion der Harnblase. Die verminderte Dehnbarkeit des Detrusors kann zu einer Druckbelastung des oberen Harntrakts f\u00fchren, aber auch drangdominante LUTS und Harnwegsinfektionen k\u00f6nnen resultieren. Neurogene Ursachen, v.a. die Querschnittsl\u00e4hmung\/Spina bifida aber auch iatrogene Sch\u00e4den oder eine subvesikale Obstruktion k\u00f6nnen u.a. zur Entstehung beitragen. Der Beitrag soll \u00fcber die Verbreitung und komplexen pathogenetischen Mechanismen, aber auch notwendige diagnostische Schritte informieren. Unterschiedliche medikament\u00f6se, interventionelle und operative Behandlungsstrategien werden anhand aktueller wissenschaftlicher Erkenntnisse bewertet und der Leser so in der Betreuung dieses komplexen Patientenklientels unterst\u00fctzt.<\/jats:p>","DOI":"10.1055\/a-2287-4933","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T23:35:05Z","timestamp":1713915305000},"page":"302-307","source":"Crossref","is-referenced-by-count":0,"title":["\u201ePressure kills kidneys\u201c: Schutz des oberen Harntrakts durch neuro-urologisches Management"],"prefix":"10.1055","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2486-2740","authenticated-orcid":false,"given":"Fabian","family":"Quei\u00dfert","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Urologie und Kinderurologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres Jan","family":"Schrader","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Urologie und Kinderurologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s0090-4295(83)80034-x","article-title":"History of cystometry","volume":"22","author":"A Ek","year":"1983","journal-title":"Urology"},{"key":"ref2","first-page":"472","article-title":"Neurogenic bladder: pathophysiology of the disorder of compliance","volume":"14","author":"E Chartier-Kastler","year":"2004","journal-title":"Prog Urol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/nau.20713","article-title":"The clinical significance of poor bladder compliance","volume":"28","author":"SY Cho","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0022-5347(05)67730-0","article-title":"Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients","volume":"163","author":"KJ Weld","year":"2000","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.prnil.2017.01.008","article-title":"Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction","volume":"5","author":"CHS Bellucci","year":"2017","journal-title":"Prostate Int"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"E664","DOI":"10.5489\/cuaj.7265","article-title":"Impact of radiotherapy for localized prostate cancer on bladder function as demonstrated on urodynamics study: A systematic review","volume":"15","author":"HH Yao","year":"2021","journal-title":"Can Urol Assoc J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/IGC.0b013e318204c3df","article-title":"Risk factors for persistent low bladder compliance after radical hysterectomy","volume":"21","author":"Y Oda","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11255-022-03399-8","article-title":"Factors associated with low-compliance bladder in end-stage renal disease patients and development of a clinical prediction model for urodynamic evaluation: the DUDi score","volume":"55","author":"T Tangpaitoon","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.5980\/jpnjurol1989.82.1594","article-title":"Serious complications of intravesical bacillus Calmette-Guerin therapy in patients with bladder cancer","volume":"82","author":"S Kudo","year":"1991","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/s0022-5347(17)39761-6","article-title":"The value of leak pressure and bladder compliance in the urodynamic evaluation of meningomyelocele patients","volume":"144","author":"GM Ghoniem","year":"1990","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0022-5347(17)54449-3","article-title":"Prognostic value of urodynamic testing in myelodysplastic patients","volume":"126","author":"EJ McGuire","year":"1981","journal-title":"J Urol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/s0090-4295(99)00553-1","article-title":"Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury","volume":"55","author":"KJ Weld","year":"2000","journal-title":"Urology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/nau.23501","article-title":"Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review","volume":"37","author":"S Musco","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/01.ju.0000047124.26901.2a","article-title":"bstructive uropathy induced bladder dysfunction can be reversible: bladder compliance measures before and after treatment","volume":"169","author":"WW Leng","year":"2003","journal-title":"O J Urol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/iju.14319","article-title":"Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and\/or low compliance bladder","volume":"27","author":"K Kaga","year":"2020","journal-title":"Int J Urol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/sc.2012.164","article-title":"Effects of solifenacin in patients with neurogenic detrusor overactivity as a\n          result of spinal cord lesion","volume":"51","author":"J Krebs","year":"2013","journal-title":"E Spinal Cord"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/iju.14244","article-title":"Efficacy and safety of mirabegron for the treatment of low compliance bladder resulting from sacral\/infrasacral lesions: A prospective study","volume":"27","author":"P Vasudeva","year":"2020","journal-title":"Int J Urol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.juro.2009.05.038","article-title":"Combination drug therapy improves compliance of the neurogenic bladder","volume":"182","author":"AP Cameron","year":"2009","journal-title":"J Urol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/nau.22755","article-title":"Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: A randomized, prospective, controlled multi-center trial","volume":"35","author":"A Schroder","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"F Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"D Ginsberg","year":"2012","journal-title":"J Urol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"520 e521","DOI":"10.1016\/j.jpurol.2021.02.020","article-title":"Factors predicting the success of intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort","volume":"17","author":"YO Danacioglu","year":"2021","journal-title":"J Pediatr Urol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/nau.21124","article-title":"Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele","volume":"30","author":"M Horst","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1097\/01.ju.0000110793.73623.c1","article-title":"The outcome of detrusor myotomy in children with neurogenic bladder dysfunction","volume":"171","author":"YF Rawashdeh","year":"2004","journal-title":"J Urol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/nau.21239","article-title":"Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results","volume":"31","author":"N Gobeaux","year":"2012","journal-title":"Neurourol Urodyn"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e1736","DOI":"10.1097\/MD.0000000000001736","article-title":"Chronic Indwelling Urinary Catheter Increase the Risk of Bladder Cancer, Even in Patients Without Spinal Cord Injury.","volume":"94","author":"CH Ho","year":"2015","journal-title":"Medicine"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e050728","DOI":"10.1136\/bmjopen-2021-050728","article-title":"Association between chronic bladder catheterisation and bladder cancer incidence and mortality: a population-based retrospective cohort study in Ontario, Canada","volume":"11","author":"AE Hird","year":"2021","journal-title":"BMJ Open"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/RRU.S29644","article-title":"Neurogenic bladder in spinal cord injury patients","volume":"7","author":"WA Taweel","year":"2015","journal-title":"Res Rep Urol"}],"container-title":["Aktuelle Urologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2287-4933.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:16:11Z","timestamp":1730826971000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2287-4933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":28,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,7,24]]},"published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2287-4933","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0001-7868","1438-8820"],"issn-type":[{"type":"print","value":"0001-7868"},{"type":"electronic","value":"1438-8820"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}